One of the quieter decisions in TAIMWAS was also one of the most discussed: the system does not simply give a single answer. It also shows how confident it is.
The reason is simple: a model that is quietly wrong is dangerous in a clinical setting. If the system is unsure about what it sees in a wound image, the clinician should see that uncertainty plainly and make the call themselves, not be handed a smoothed-over answer.
Why this is harder than it sounds
A model can be accurate on average and still be poor at knowing when it is wrong. What matters clinically is whether its stated confidence can be trusted: when it says it is 90% sure, is it right about 90% of the time? That property is called calibration, and it has to be checked separately from accuracy.
It also has to hold for every patient group, not just on average. Published wound-image collections tend to under-represent darker skin tones, so a system that looks well calibrated overall can be least reliable for the patients who are least represented.
What we took from it
We treat calibration as part of how a system is evaluated, checked across the groups of people it will be used on, and not as an optional extra at the end. If you cannot say how often a confident prediction is correct for those people, you have a demo, not a system ready for clinical use.
This now shapes how we scope healthcare and other high-stakes AI work. It adds engineering time at the start. It saves more later, when the system has to explain its outputs to an auditor, a regulator or a clinician who saw an unexpected result.
Posted by the Smartifier team.